Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Recent studies have indicated the existence of tumorigenesis barriers that slow or inhibit the progression of preneoplastic lesions to neoplasia. One such barrier involves DNA replication stress, which leads to activation of the DNA damage checkpoint and thereby to apoptosis or cell cycle arrest, whereas a second barrier is mediated by oncogene-induced senescence. The relationship between these two barriers, if any, has not been elucidated. Here we show that oncogene-induced senescence is associated with signs of DNA replication stress, including prematurely terminated DNA replication forks and DNA double-strand breaks. Inhibiting the DNA double-strand break response kinase ataxia telangiectasia mutated (ATM) suppressed the induction of senescence and in a mouse model led to increased tumour size and invasiveness. Analysis of human precancerous lesions further indicated that DNA damage and senescence markers cosegregate closely. Thus, senescence in human preneoplastic lesions is a manifestation of oncogene-induced DNA replication stress and, together with apoptosis, provides a barrier to malignant progression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Oncogene activation is a powerful inducer of cellular senescence. Oncogene expression triggers an initial hyperproliferative phase that is intrinsically associated with altered DNA replication, which eventually engages DDR pathways and causes senescence7,8,39”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [8]
In the citing paper
“It has been shown that one mechanism for the link between the initial mitotic reaction and senescence induction is the S-phase-associated DDR: The oncogenic stress drives increased DNA replication origins, leading to accumulation of incomplete replication intermediates, resulting in DNA damage and activation of the DDR kinases (ATM, ATR, CHK2, and CHK1) (Bartkova et al. 2006; Di Micco et al. 2006;”
From Cellular senescence and its effector programs (2014) · cites this paper as Bartkova et al. 2006
In the citing paper
“Colon adenomas, which are stable precursor lesions of invasive colon cancer, were found to be negative for the proliferation marker Ki67 and positive for SA- β- gal 87,88 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [87]
In the citing paper
“colon adenoma- derived samples also have elevated expression of p16 INK4a , HP1γ (an H3K9me3- enriched senescence- associated heterochromatin focus- promoting scaffold that connects H3K9 methyltransferases to Rb as another binding partner), and focal γH2AX expression, indicating enhanced DNA damage 87,89 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [87]
In the citing paper
“In particular, E1A inhibits p53 phosphorylation at serine 15 (14), a hallmark of the activation of the DNA damage response during senescence (3, 12).”
From Mitochondrial Dysfunction Contributes to Oncogene-Induced Senescence (2009) · cites this paper as [3]
9 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
A System for Stable Expression of Short Interfering RNAs in Mammalian Cells
Brummelkamp, T. R., Bernards, R., & Agami, R. (2002) · Science · doi:10.1126/science.1068999 · Cited by 4,291
A DNA damage checkpoint response in telomere-initiated senescence
Fagagna, F. D. D., Reaper, P. M., Clay-Farrace, L., Fiegler, H., Carr, P., von Zglinicki, T., Saretzki, G., Carter, N. P., & Jackson, S. P. (2003) · Nature · doi:10.1038/nature02118 · Cited by 2,917
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
Bartkova, J., Hořejší, Z., Koed, K., Krämer, A., Tort, F., Zieger, K., Guldberg, P., Sehested, M., Nesland, J. M., Lukas, C., et al. (2005) · Nature · doi:10.1038/nature03482 · Cited by 2,688
Self-citationRb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278
BRAFE600-associated senescence-like cell cycle arrest of human naevi
Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., van der Horst, C. M. A. M., Majoor, D. M., Shay, J. W., Mooi, W. J., & Peeper, D. S. (2005) · Nature · doi:10.1038/nature03890 · Cited by 2,160
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions
Gorgoulis, V. G., Vassiliou, L.-V. F., Karakaidos, P., Zacharatos, P., Kotsinas, A., Liloglou, T., Venere, M., DiTullio, R. A., Kastrinakis, N. G., Levy, B., et al. (2005) · Nature · doi:10.1038/nature03485 · Cited by 2,009
Self-citationCrucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
Chen, Z., Trotman, L. C., Shaffer, D., Lin, H.-K., Dotan, Z. A., Niki, M., Koutcher, J. A., Scher, H. I., Ludwig, T., Gerald, W., et al. (2005) · Nature · doi:10.1038/nature03918 · Cited by 1,993
Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication
Di Micco, R., Fumagalli, M., Cicalese, A., Piccinin, S., Gasparini, P., Luise, C., Schurra, C., Garre’, M., Giovanni Nuciforo, P., Bensimon, A., et al. (2006) · Nature · doi:10.1038/nature05327 · Cited by 1,821
Senescence in premalignant tumours
Collado, M., Gil, J., Efeyan, A., Guerra, C., Schuhmacher, A. J., Barradas, M., Benguría, A., Zaballos, A., Flores, J. M., Barbacid, M., et al. (2005) · Nature · doi:10.1038/436642a · Cited by 1,482
Cited by
Items 301–400 of 1,016
Derepression of hTERT gene expression promotes escape from oncogene-induced cellular senescence
Patel, P. L., Suram, A., Mirani, N., Bischof, O., & Herbig, U. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1602379113 · Cited by 142
“The ensuing DNA damage response (DDR) triggers OIS, thereby arresting cells within a few cell-division cycles after oncogene expression (8, 9).”
BackgroundProapoptotic Function of the Retinoblastoma Tumor Suppressor Protein
Ianari, A., Natale, T., Calo, E., Ferretti, E., Alesse, E., Screpanti, I., Haigis, K., Gulino, A., & Lees, J. A. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.026 · Cited by 135
“Given the recent finding that oncogenic stress activates the DNA damage response (Bartkova et al., 2006; Di Micco et al., 2006), formation of the transcriptionally active pRB-E2F1 complexes may be further reinforced through E1A’s activation of the DNA damage-dependent process.”
Cellular senescence and cancer chemotherapy resistance
Gordon, R. R., & Nelson, P. S. (2012) · Drug Resistance Updates · doi:10.1016/j.drup.2012.01.002 · Cited by 134
“The ATM pathway has also been implicated in initiating a senescence response following perturbation of the oncogenes mos, cdc6 and Cyclin E (Bartkova et al., 2006).”
BackgroundChromothripsis: Chromosomes in Crisis
Jones, M. J. K., & Jallepalli, P. V. (2012) · Developmental Cell · doi:10.1016/j.devcel.2012.10.010 · Cited by 130
“, Cdc6 and cyclin E) can induce both replication stress and S phasespecific DSBs in primary cells (Bartkova et al., 2006; Di Micco et al., 2006), possibly through precocious origin firing and accelerated depletion of nucleotide pools (Bester et al.”
BackgroundCancer and Aging - the Inflammatory Connection
Zinger, A., Cho, W. C., & Ben-Yehuda, A. (2017) · Aging and disease · doi:10.14336/ad.2016.1230 · Cited by 136
Efeyan, A., Ortega-Molina, A., Velasco-Miguel, S., Herranz, D., Vassilev, L. T., & Serrano, M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0200 · Cited by 140
Survival Benefit for Pediatric Patients With Recurrent Ependymoma Treated With Reirradiation
Bouffet, É., Hawkins, C. E., Ballourah, W., Taylor, M. D., Bartels, U. K., Schoenhoff, N. J., Tsangaris, E., Huang, A., Kulkarni, A. V., Mabbott, D., et al. (2012) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2011.10.039 · Cited by 140
Replication fork dynamics and the DNA damage response
Jones, R. M., & Petermann, E. (2012) · Biochemical Journal · doi:10.1042/bj20112100 · Cited by 164
Senescent cells communicate via intercellular protein transfer
Biran, A., Perelmutter, M., Gal, H., Burton, D. G. A., Ovadya, Y., Vadai, E., Geiger, T., & Krizhanovsky, V. (2015) · Genes & Development · doi:10.1101/gad.259341.115 · Cited by 139
“…senescent in response to persistent DNA damage triggered by telomere shortening, exposure to a DNA- damaging agent, or expression of activated oncogenes (Serrano et al. 1997; Vaziri et al. 1997; Bartkova et al. 2006; Di Micco et al. 2006; Campisi and d’Adda di Fagagna 2007; Mallette et al. 2007).”
Rai, P., Young, J. J., Burton, D. G. A., Giribaldi, M. G., Önder, T. T., & Weinberg, R. A. (2010) · Oncogene · doi:10.1038/onc.2010.520 · Cited by 141
Li, Y., Shen, Y., Hohensinner, P., Ju, J., Wen, Z., Goodman, S. B., Zhang, H., Goronzy, J. J., & Weyand, C. M. (2016) · Immunity · doi:10.1016/j.immuni.2016.09.013 · Cited by 137
“More difficult to understand is the p21-gain and p53-loss combination, as DNA-damage-induced ATM-p53-p21 signaling typically drives growth arrest of senescent T cells (Bartkova et al., 2006; Fumagalli et al., 2014; Nakamura et al., 2008; Rodier et al., 2011).”
AURKB as a target in non-small cell lung cancer with acquired resistance to anti-EGFR therapy
Bertran-Alamillo, J., Cattan, V., Schoumacher, M., Codony-Servat, J., Giménez-Capitán, A., Cantero, F., Burbridge, M., Rodríguez, S., Teixidó, C., Roman, R., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09734-5 · Cited by 138
Krizhanovsky, V., Xue, W., Zender, L., Yon, M., Hernando, E., & Lowe, S. W. (2008) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2008.73.048 · Cited by 138
“The nature of this signal is the topic of much debate and likely involves activation of the INK4a/ARF locus as well as a DNA-damage response through signals produced by replication stress (Bartkova et al. 2006; Di Micco et al. 2006).”
BackgroundReplication stress and cancer: It takes two to tango
Lecona, E., & Fernández-Capetillo, O. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.09.019 · Cited by 132
Progress towards a clinically-successful ATR inhibitor for cancer therapy
Barnieh, F. M., Loadman, P. M., & Falconer, R. A. (2021) · Current Research in Pharmacology and Drug Discovery · doi:10.1016/j.crphar.2021.100017 · Cited by 143
Hedgehog signaling overrides p53-mediated tumor suppression by activating Mdm2
Abe, Y., Oda-Sato, E., Tobiume, K., Kawauchi, K., Taya, Y., Okamoto, K., Oren, M., & Tanaka, N. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712216105 · Cited by 136
“Recent studies have clearly shown that oncogene activation evokes a DNA-damage response, which results in p53 activation (12, 13).”
BackgroundInfluentialOur Conflict with Transposable Elements and Its Implications for Human Disease
Burns, K. H. (2020) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012419-032633 · Cited by 137
“However, it is plausible that the DNA damage it exacts transforms cells or that it puts cells in a state analogous to oncogene-induced senescence (120, 121), creating selective advantages for preneoplastic populations of cells with critical tumor suppressor mutations.”
BackgroundTakeuchi, S., Takahashi, A., Motoi, N., Yoshimoto, S., Tajima, T., Yamakoshi, K., Hirao, A., Yanagi, S., Fukami, K., Ishikawa, Y., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0801 · Cited by 136
Venkatesan, S., Angelova, M., Puttick, C., Zhai, H.-R., Caswell, D. R., Lu, W.-T., Dietzen, M., Galanos, P., Evangelou, K., Bellelli, R., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-0725 · Cited by 150
“Pre-invasive lesions contain epithelial cells undergoing replication stress, and this could result in either senescence (38) or transformation and unchecked proliferation.”
BackgroundSelf-citationMechanisms and Consequences of Cancer Genome Instability: Lessons from Genome Sequencing Studies
Lee, J.-K., Choi, Y.-L., Kwon, M., & Park, P. J. (2016) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012615-044446 · Cited by 135
Cerrato, A., Morra, F., & Celetti, A. (2016) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-016-0456-2 · Cited by 129
Role of MAPK pathway oncoproteins in thyroid cancer pathogenesis and as drug targets
Knauf, J. A., & Fagin, J. A. (2009) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.01.013 · Cited by 143
Efficacy of CHK inhibitors as single agents in MYC-driven lymphoma cells
Ferrao, P. T., Bukczynska, E. P., Johnstone, R. W., & McArthur, G. A. (2012) · Oncogene · doi:10.1038/onc.2011.358 · Cited by 133
Alternative Cyclin D1 Splice Forms Differentially Regulate the DNA Damage Response
Li, Z., Jiao, X., Wang, C., Shirley, L. A., Elsaleh, H., Dahl, O., Wang, M., Soutoglou, E., Knudsen, E. S., & Pestell, R. G. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0312 · Cited by 124
A novel non‐coding RNA lncRNA‐JADE connects DNA damage signalling to histone H4 acetylation
Wan, G., Hu, X., Liu, Y., Han, C., Sood, A. K., Călin, G. A., Zhang, X., & Lu, X. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.221 · Cited by 141
“We showed here that lncRNA-JADE is upregulated in a high percentage of breast tumours, consistent with the previous studies showing hyperactive DDR activity in human breast cancer progression (Bartkova et al , 2006; Halazonetis et al , 2008).”
DNA Damage Signaling Instructs Polyploid Macrophage Fate in Granulomas
Herrtwich, L., Nanda, I., Evangelou, K., Nikolova, T., Horn, V., Sagar, Erny, D., Stefanowski, J., Rogell, L., Klein, C., et al. (2016) · Cell · doi:10.1016/j.cell.2016.09.054 · Cited by 138
“Oncogene-induced RS is a barrier toward tetraploidy and tumorigenesis since the DDR induces cell-cycle arrest and p53-dependent cell death (Bartkova et al., 2006; Gorgoulis et al., 2005).”
Self-citationAPOBEC3A and APOBEC3B Activities Render Cancer Cells Susceptible to ATR Inhibition
Buisson, R., Lawrence, M. S., Benes, C. H., & Zou, L. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-3389 · Cited by 139
DNA replication stress and cancer chemotherapy
Kitao, H., Iimori, M., Kataoka, Y., Wakasa, T., Tokunaga, E., Saeki, H., Oki, E., & Maehara, Y. (2017) · Cancer Science · doi:10.1111/cas.13455 · Cited by 146
Shibata, T., Saito, S., Kokubu, A., Suzuki, T., Yamamoto, M., & Hirohashi, S. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0384 · Cited by 128
Aggarwal, P., Lessie, M. D., Lin, D. I., Pontano, L., Gladden, A. B., Nuskey, B., Goradia, A., Wasik, M. A., Klein-Szanto, A. J. P., Rustgi, A. K., et al. (2007) · Genes & Development · doi:10.1101/gad.1586007 · Cited by 132
“Recent work has correlated oncogene-induced senescence with induction of the DNA damage checkpoint in solid tumors (Bartkova et al. 2006; Di Micco et al. 2006).”
BackgroundWitkiewicz, A. K., & Knudsen, E. S. (2014) · Breast Cancer Research · doi:10.1186/bcr3652 · Cited by 125
“For example, high levels of p16ink4a in benign Nevi are believed to contribute to potent suppression of melanoma [18].”
BackgroundWilliamson, C. T., Kubota, E., Hamill, J. D., Klimowicz, A. C., Ye, R., Muzik, H., Dean, M. L., Tu, L., Gilley, D. P., Magliocco, A. M., et al. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201200229 · Cited by 140
“DNA damage-induced phosphorylation and stabilization of p53 is critical for maintaining genomic stability and acts as a barrier to tumourigenesis (Bartkova et al, 2006).”
Velimezi, G., Liontos, M., Vougas, K., Roumeliotis, T., Bartkova, J., Sideridou, M., Dereli-Oz, A., Kocylowski, M., Pateras, I. S., Evangelou, K., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2795 · Cited by 131
Self-citationIndividual-level analysis of differential expression of genes and pathways for personalized medicine
Wang, H., Sun, Q., Zhao, W., Qi, L., Gu, Y., Li, P., Zhang, M., Li, Y., Liu, S., & Guo, Z. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu522 · Cited by 132
Vougas, K. N., Sakellaropoulos, T., Kotsinas, A., Foukas, G.-R. P., Ntargaras, A., Koinis, F., Polyzos, A., Myrianthopoulos, V., Zhou, H., Narang, S., et al. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.107395 · Cited by 140
Self-citationKnudsen, E. S., Kumarasamy, V. M., Nambiar, R., Pearson, J. D., Vail, P. J., Rosenheck, H. R., Wang, J., Eng, K., Bremner, R., Schramek, D., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110448 · Cited by 141
Extranuclear DNA accumulates in aged cells and contributes to senescence and inflammation
Lan, Y. Y., Heather, J. M., Eisenhaure, T., Garris, C. S., Lieb, D., Raychowdhury, R., & Hacohen, N. (2019) · Aging Cell · doi:10.1111/acel.12901 · Cited by 130
Splicing-Factor Oncoprotein SRSF1 Stabilizes p53 via RPL5 and Induces Cellular Senescence
Fregoso, O. I., Das, S., Akerman, M., & Krainer, A. R. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.02.001 · Cited by 135
“…by SRSF1 overexpression in normal cells is distinct from the classical Rasinduced senescence (Serrano et al., 1997), which is primarily a DNA-damage response induced by hyperproliferation, and is dependent on p16 activation (Bartkova et al., 2006; Chicas et al., 2010; Di Micco et al., 2006).”
BackgroundOral Lichen Planus as a Preneoplastic Inflammatory Model
Georgakopoulou, E. A., Achtari, M. D., Achtaris, M., Foukas, P. G., & Kotsinas, A. (2012) · BioMed Research International · doi:10.1155/2012/759626 · Cited by 141
“Such conditions should activate the DNA damage response (DDR) checkpoint [41, 42].”
BackgroundMallette, F. A., & Richard, S. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.09.033 · Cited by 120
“This DNA damage response triggered by the PIK-related kinase ATM is required to activate p53 during OIS (Bartkova et al., 2006; Di Micco et al., 2006; Mallette et al., 2007).”
BackgroundA ‘DNA replication’ signature of progression and negative outcome in colorectal cancer
Pillaire, M., Sèlves, J., Gordien, K., Gourraud, P., Gentil, C., Danjoux, M., Do, C., Negre, V., Bieth, A., Guimbaud, R., et al. (2009) · Oncogene · doi:10.1038/onc.2009.378 · Cited by 135
The role of oxidative DNA damage in radiation induced bystander effect
Havaki, S., Kotsinas, A., Chronopoulos, E., Kletsas, D., Georgakilas, A. G., & Gorgoulis, V. G. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.01.023 · Cited by 134
Self-citationJia, L., Soengas, M. S., & Sun, Y. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4671 · Cited by 131
Maciel-Barón, L. A., Morales-Rosales, S. L., Aquino-Cruz, A. A., Triana-Martínez, F., Galván-Arzate, S., Luna-López, A., González-Puertos, V. Y., López-Díazguerrero, N. E., Torres, C., & Königsberg, M. (2016) · AGE · doi:10.1007/s11357-016-9886-1 · Cited by 128
“…stimuli such as oxidative stress and radiation exposure (Toussaint et al. 2000; López-Diazguerrero et al. 2006; Lee et al. 2011), autophagy impairment (Kang et al. 2011; Fujii et al. 2012), proteasome inhibition (Torres et al. 2006; Bitto et al. 2010), and oncogenic stress (Bartkova et al. 2006).”
BackgroundThe role of Stat5 transcription factors as tumor suppressors or oncogenes
Ferbeyre, G., & Moriggl, R. (2010) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2010.10.004 · Cited by 143
Common Chemical Inductors of Replication Stress: Focus on Cell‐Based Studies
Vesela, E., Chroma, K., Turi, Z., & Mistrik, M. (2017) · Biomolecules · doi:10.3390/biom7010019 · Cited by 115
“Moreover, a causative role of CFS’s in cancer development has been suggested [191].”
BackgroundInfluentialThe Paradoxical Role of Cellular Senescence in Cancer
Yang, J., Liu, M., Hong, D., Zeng, M., & Zhang, X. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.722205 · Cited by 114
“studies reported that DNA damage is caused by oncogeneinduced DNA replication stress (Lee et al., 1999; Bartkova et al., 2006; Di Micco et al., 2006).”
BackgroundInfluentialCellular senescence and cardiovascular diseases: moving to the “heart” of the problem
Evangelou, K., Vasileiou, P. V. S., Papaspyropoulos, A., Hazapis, O. G., Petty, R., Demaria, M., & Gorgoulis, V. G. (2022) · Physiological Reviews · doi:10.1152/physrev.00007.2022 · Cited by 136
Self-citationCytokine expression and signaling in drug-induced cellular senescence
Novakova, Z., Hubackova, S., Kosar, M., Janderova-Rossmeislova, L., Dobrovolna, J., Vasicova, P., Vancurova, M., Horejsi, Z., Hozak, P., Bartek, J., et al. (2010) · Oncogene · doi:10.1038/onc.2009.318 · Cited by 127
“…of cells undergoing senescence in vitro were also found in preinvasive lesions of multiple types of human tumors (Michaloglou et al., 2005; Bartkova et al., 2006; Di Micco et al., 2006; Collado et al., 2007; Acosta et al., 2008; Kuilman et al., 2008), supporting a view that cellular…”
BackgroundA Synergistic Interaction between Chk1- and MK2 Inhibitors in KRAS-Mutant Cancer
Dietlein, F., Kalb, B., Jokić, M., Noll, E. M., Strong, A., Tharun, L., Ozretić, L., Künstlinger, H., Kambartel, K.-O., Randerath, W. J., et al. (2015) · Cell · doi:10.1016/j.cell.2015.05.053 · Cited by 129
Rasmussen, R. D., Gajjar, M. K., Tučková, L., Jensen, K. E., Maya‐Mendoza, A., Holst, C. B., Møllgaard, K., Rasmussen, J. S., Brennum, J., Bartek, J. J., et al. (2016) · Nature Communications · doi:10.1038/ncomms13398 · Cited by 135
“DSBs trigger the DNA damage response (DDR) network including checkpoints that provide an intrinsic barrier to carcinogenesis 12,13 .”
Self-citationRegulation of cellular senescence via the FOXO 4‐p53 axis
Bourgeois, B., & Madl, T. (2018) · FEBS Letters · doi:10.1002/1873-3468.13057 · Cited by 119
Cellular senescence: Neither irreversible nor reversible
Reimann, M., Lee, S., & Schmitt, C. A. (2024) · The Journal of Experimental Medicine · doi:10.1084/jem.20232136 · Cited by 136
“(cid:129) γ -H2AX immunostaining to mark DNA damage foci (Bartkova et al., 2006).”
BackgroundLoss of Rb proteins causes genomic instability in the absence of mitogenic signaling
van Harn, T., Foijer, F., van Vugt, M., Banerjee, R., Yang, F., Oostra, A., Joenje, H., & te Riele, H. (2010) · Genes & Development · doi:10.1101/gad.580710 · Cited by 124
“Interestingly, a DDR has been observed previously upon activation of various oncogenes, and has been as- cribed to stalling and collapse of replication forks (Bartkova et al. 2006; Di Micco et al. 2006; Halazonetis et al. 2008).”
BackgroundThe DNA Damage Signaling Pathway Connects Oncogenic Stress to Cellular Senescence
Mallette, F. A., & Ferbeyre, G. (2007) · Cell Cycle · doi:10.4161/cc.6.15.4516 · Cited by 125
Leung, J. W.-C., Ghosal, G., Wang, W., Shen, X., Wang, J., Li, L., & Chen, J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.411603 · Cited by 117
“Impaired replication fork progression and increased replication-dependent DNA damage were found in early stages of tumor development (35, 36).”
Hein, J., Boichuk, S., Wu, J., Cheng, Y., Freire, R., Jat, P., Roberts, T. M., & Gjoerup, O. V. (2008) · Journal of Virology · doi:10.1128/jvi.01515-08 · Cited by 137
“Recent reports have demonstrated that both replicative and oncogene-induced senescences reflect an underlying persistent activation of DDRs that are likely triggered by aberrant cellular DNA replication (4, 17, 21).”
BackgroundEvangelou, K., & Gorgoulis, V. G. (2017) · Methods in Molecular Biology · doi:10.1007/978-1-4939-6670-7_10 · Cited by 124
Self-citationAllera-Moreau, C., Rouquette, I., Lepage, B., Oumouhou, N., Walschaerts, M., Leconte, E., Schilling, V, Gordien, K., Brouchet, L., Delisle, M. B., et al. (2012) · Oncogenesis · doi:10.1038/oncsis.2012.29 · Cited by 116
Oocytes Progress beyond Prophase in the Presence of DNA Damage
Marangos, P., & Carroll, J. (2012) · Current Biology · doi:10.1016/j.cub.2012.03.063 · Cited by 127
“Mouse Oocytes Enter M Phase in the Presence of DNA Damage In somatic cells, at the G2 stage, DNA double-strand breaks cause the autophosphorylation and subsequent activation of the master DNA damage checkpoint regulator, ATM (ataxia telangiectasia mutated) kinase [3, 4].”
Skin-Aging Pigmentation: Who Is the Real Enemy?
Kim, J. C., Park, T. J., & Kang, H. Y. (2022) · Cells · doi:10.3390/cells11162541 · Cited by 136
“Oncogenic activation, such as RAS or BRAF, engaging the DDR pathways is another cause of cellular senescence [72,73], known as oncogene-induced senescence (OIS).”
BackgroundDNA Methylation Patterns Separate Senescence from Transformation Potential and Indicate Cancer Risk
Xie, W., Kagiampakis, I., Pan, L., Zhang, Y. W., Murphy, L., Tao, Y., Kong, X., Kang, B., Xia, L., Carvalho, F. L. F., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.01.008 · Cited by 122
“The latter senescence mode is highly relevant to the choice between resistance versus becoming addicted to oncogenic signaling (Bartkova et al., 2006; Lowe et al., 2004; Michaloglou et al., 2005; Sarkisian et al., 2007).”
Fan, G., Yu, B., Tang, L., Zhu, R., Chen, J., Zhu, Y., Huang, H., Zhou, L., Liu, J., Wang, W., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adj5705 · Cited by 128
Burton, D. G. A., Matsubara, H., & Ikeda, K. (2010) · Experimental Gerontology · doi:10.1016/j.exger.2010.07.005 · Cited by 121
Guidi, R., Guerra, L., Levi, L., Stenerlöw, B., Fox, J. G., Josenhans, C., Masucci, M. G., & Frisan, T. (2013) · Cellular Microbiology · doi:10.1111/cmi.12034 · Cited by 111
“The DDR provides an efficient barrier to tumorigenesis through induction of cell death or senescence (Bartkova et al., 2006; Halazonetis et al., 2008).”
Nayak, S. U., Calvo, J. A., Cong, K., Peng, M., Berthiaume, E. A., Jackson, J., Zaino, A. M., Vindigni, A., Hadden, M. K., & Cantor, S. B. (2020) · Science Advances · doi:10.1126/sciadv.aaz7808 · Cited by 123
The great unravelling: chromatin as a modulator of the aging process
O'Sullivan, R. J., & Karlseder, J. (2012) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2012.08.001 · Cited by 116
“By contrast, oncogene induced senescence (OIS), which coincides with SAHF formation, arises from an acute stress at stalled replication forks, leading to irreparable DNA damage [72].”
BackgroundMechanisms to control rereplication and implications for cancer
Hook, S. S., Lin, J. J., & Dutta, A. (2007) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2007.10.007 · Cited by 138
Stressing the cell cycle in senescence and aging
Chandler, H., & Peters, G. (2013) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2013.07.005 · Cited by 119
Yin, Y., Xu, L., Chang, Y., Zeng, T., Chen, X., Wang, A., Groth, J., Foo, W., Liang, C. Y., Hu, H., et al. (2019) · Molecular Cancer · doi:10.1186/s12943-019-0941-2 · Cited by 119
“ATM kinase is well known for its essential role in oncogene-induced senescence [3, 15, 26].”
BackgroundCellular senescence: hot or what?
Evan, G. I., & di Fagagna, F. D. (2009) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2008.11.009 · Cited by 151
Barash, H., R. Gross, E., Edrei, Y., Ella, E., Israel, A., Cohen, I., Corchia, N., Ben-Moshe, T., Pappo, O., Pikarsky, E., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908867107 · Cited by 116
“It is apparent that the DNA damage response has a role as a barrier in tumor progression and that replication stress is an underlying trigger of oncogene-induced DNA damage response (52, 53).”
BackgroundWu, Z., Qu, J., & Liu, G.-H. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-024-00775-3 · Cited by 118
“For example, oncogene activation can induce extensive replication fork stalling, thereby inducing a robust DDR, which in turn results in growth arrest and senescence in normal human fibroblasts, without involving telomere attrition 117–119 .”
Insua‐Rodríguez, J., Pein, M., Hongu, T., Meier, J., Descot, A., Lowy, C. M., De Braekeleer, E., Sinn, H., Spaich, S., Sütterlin, M., et al. (2018) · EMBO Molecular Medicine · doi:10.15252/emmm.201809003 · Cited by 110
“Intracellular stress can arise from overexpression of oncogenes, poor protein folding, and a high replicative state (Bartkova et al, 2006; Di Micco et al, 2006; Clarke et al, 2014; Minocherhomji et al, 2015).”
BackgroundCellular senescence predicts treatment outcome in metastasised colorectal cancer
Haugstetter, A. M., Loddenkemper, C., Lenze, D., Gröne, J., Standfuß, C., Petersen, I., Dörken, B., & Schmitt, C. A. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605784 · Cited by 117
“Oncogene-induced senescence is mediated through an oncogene-evoked DNA damage response (DDR) (Bartkova et al, 2005, 2006; Gorgoulis et al, 2005), thereby explaining why DNA-damaging chemotherapy produces senescence as well (Chang et al, 1999; Schmitt et al, 2002).”
BackgroundMethodInfluentialPrieur, A., Besnard, E., Babled, A., & Lemaitre, J.-M. (2011) · Nature Communications · doi:10.1038/ncomms1473 · Cited by 117
“Activation of the DNA damage response (DDR), triggered by DNA single-strand and/or double-strand breaks, has been described as a common feature of telomere-initiated or OI”
BackgroundTargeting DNA repair, DNA metabolism and replication stress as anti‐cancer strategies
Puigvert, J. C., Sanjiv, K., & Helleday, T. (2016) · The FEBS Journal · doi:10.1111/febs.13574 · Cited by 113
Self-citationMetabolic stress is a barrier to Epstein–Barr virus-mediated B-cell immortalization
McFadden, K., Hafez, A. Y., Kishton, R., Messinger, J. E., Nikitin, P. A., Rathmell, J. C., & Luftig, M. A. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1517141113 · Cited by 118
“Cold Spring Harb Perspect Biol 4(9):a008763.”
Bártková, J., Hořejší, Z., Sehested, M., Nesland, J. M., Meyts, E. R., Skakkebæk, N. E., Stucki, M., Jackson, S. P., Lukáš, J., & Bártek, J. (2007) · Oncogene · doi:10.1038/sj.onc.1210553 · Cited by 128
“…create an environment in which inactivating mutations within the DDR network are selected for in lesions that eventually overcome the DDR-induced cell death or senescence pathways and progress towards malignancy (Bartkova et al., 2005b, 2006; Gorgoulis et al., 2005; Di Micco et al., 2006).”
BackgroundSelf-citationSchmitt, E., Paquet, C., Beauchemin, M., & Bertrand, R. (2007) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.2007.b0377 · Cited by 152
Maehara, K., Takahashi, K., & Saitoh, S. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.01318-09 · Cited by 104
“To test whether DDR plays a crucial role in p53 activation in senescencelike cells depleted of CENP-A, we examined the presence of DNA damage foci by immunofluorescence assay using antibody against phosphorylated histone H2A.”
BackgroundInfluentialDoksani, Y., Bermejo, R., Fiorani, S., Haber, J. E., & Foiani, M. (2009) · Cell · doi:10.1016/j.cell.2009.02.016 · Cited by 123
“Cells experience replication stress in response to intra-S DNA damage or oncogene-induced stimuli (Bartkova et al., 2006; Branzei and Foiani, 2005; Di Micco et al., 2006).”
Tommiska, J., Bártková, J., Heinonen, M., Hautala, L. C., Kilpivaara, O., Eerola, H., Aittomäki, K., Hofstetter, B., Lukáš, J., von Smitten, K., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210885 · Cited by 129
p53 induces transcriptional and translational programs to suppress cell proliferation and growth
Loayza-Puch, F., Drost, J., Rooijers, K., Lopes, R., Elkon, R., & Agami, R. (2013) · Genome Biology · doi:10.1186/gb-2013-14-4-r32 · Cited by 114
“of p53 and to the induction of senescence, an irreversible state of cell-cycle arrest [8,9].”
BackgroundDesaulniers, D., Xiao, G.-H., Lian, H., Feng, Y.-L., Zhu, J., Nakai, J., & Bowers, W. J. (2009) · International Journal of Toxicology · doi:10.1177/1091581809337918 · Cited by 114
Cellular senescence in aging and age-related diseases: Implications for neurodegenerative diseases
(2020) · International Review of Neurobiology · doi:10.1016/bs.irn.2020.03.019 · Cited by 114
“Senescence can mitigate risk of neoplastic transformation by removing compromised cells from the cell cycle (Bartkova et al., 2006).”
BackgroundInfluentialSasaki, M., Miyakoshi, M., Sato, Y., & Nakanuma, Y. (2010) · Laboratory Investigation · doi:10.1038/labinvest.2010.56 · Cited by 114
Synthetic Lethal Approaches Exploiting DNA Damage in Aggressive Myeloma
Cottini, F., Hideshima, T., Suzuki, R., Tai, Y.-T., Bianchini, G., Richardson, P. G., Anderson, K. C., & Tonon, G. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0943 · Cited by 115
“A recent model in epithelial cancers proposed that activated oncogenes trigger inordinate DNA replication, thereby leading to replicative stress (6, 8, 9, 13), which results in DNA DSBs.”
BackgroundActivation of the ATM-Snail pathway promotes breast cancer metastasis
Sun, M., Guo, X., Qian, X., Wang, H., Yang, C., Brinkman, K. L., Serrano-Gonzalez, M., Jope, R. S., Zhou, B., Engler, D. A., et al. (2012) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjs048 · Cited by 112
ATM Couples Replication Stress and Metabolic Reprogramming during Cellular Senescence
Aird, K. M., Worth, A. J., Snyder, N. W., Lee, J. V., Sivanand, S., Liu, Q., Blair, I. A., Wellen, K. E., & Zhang, R. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.04.014 · Cited by 113
“Similar to previous reports (Bartkova et al., 2006; Di Micco et al., 2006), RAS-induced senescence was suppressed by shATM (Figures S1W and S1X).”
Seo, J., Kim, S. C., Lee, H.-S., Kim, J. K., Shon, H. J., Salleh, N. L. M., Desai, K. V., Lee, J. H., Kang, E.-S., Kim, J. S., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks287 · Cited by 130
“Activated oncogenes result in the continuous formation of endogenous DSBs (6) due to increased replication stress (7,8).”
BackgroundViral Oncogene–Induced DNA Damage Response Is Activated in Kaposi Sarcoma Tumorigenesis
Koopal, S., Furuhjelm, J. H., Järviluoma, A., Jäämaa, S., Pyakurel, P., Pussinen, C., Wirzenius, M., Biberfeld, P., Alitalo, K., Laiho, M., et al. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030140 · Cited by 108
“DNA damage checkpoint markers like phosphorylated ATM and Chk2 kinases and phosphorylated histone H2AX and p53 are activated in precancerous lesions (early stages of tumorigenesis) of several different human cancers, including bladder, breast, colon, and lung cancer [1,2].”
InfluentialZhang, X.-B., Beard, B. C., Trobridge, G. D., Wood, B. L., Sale, G. E., Sud, R., Humphries, R. K., & Kiem, H.-P. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34371 · Cited by 108
DNA damage response and prostate cancer: defects, regulation and therapeutic implications
Karanika, S., Karantanos, T., Li, L., Corn, P. G., & Thompson, T. C. (2014) · Oncogene · doi:10.1038/onc.2014.238 · Cited by 117
Kletsas, D. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1132 · Cited by 100
Self-citationVilema-Enríquez, G., Arroyo, A., Grijalva, M., Amador-Zafra, R. I., & Camacho, J. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/1908164 · Cited by 118
“The association between DNA oxidation and DNA methylation inA549 cells exposed toH 2 O 2 has been reported by Ke et al. Hydrogen peroxide induced the formation of 5- methylcytosine (5-mC), which is a cytosine variant produced by the transfer of a methyl group to the carbon located in the fifth…”
BackgroundDirecting the use of DDR kinase inhibitors in cancer treatment
Brandsma, I., Fleuren, E. D. G., Williamson, C. T., & Lord, C. J. (2017) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2017.1389895 · Cited by 119
“the stalling or slowing of replication forks [12,13].”
BackgroundRole of H2AX in DNA damage response and human cancers
Srivastava, N., Gochhait, S., de Boer, P., & Bamezai, R. N. K. (2008) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2008.08.003 · Cited by 126
Bacterial intoxication evokes cellular senescence with persistent DNA damage and cytokine signalling
Blazkova, H., Krejcikova, K., Moudry, P., Frisan, T., Hodny, Z., & Bartek, J. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00862.x · Cited by 99
“The biological impact of the activated DDR barrier in human premalignant lesions and cellular models varies according to cell types and specific oncogenic insult, however the predominant cell fates induced by such oncogenic stress are either cell death (often apoptosis) or a long-term cell-cycle arrest state known as…”
BackgroundInfluentialSCFCyclin F-dependent degradation of CDC6 suppresses DNA re-replication
Walter, D., Hoffmann, S., Komseli, E.-S., Rappsilber, J., Gorgoulis, V. G., & Sørensen, C. S. (2016) · Nature Communications · doi:10.1038/ncomms10530 · Cited by 109
Self-citation
Metadata
- Authors
- Bartkova, J., Rezaei, N., Liontos, M., Karakaidos, P., Kletsas, D., Issaeva, N., Vassiliou, L.-V. F., Kolettas, E., Niforou, K., Zoumpourlis, V. C., Takaoka, M., Nakagawa, H., Tort, F., Fugger, K., Johansson, F., Sehested, M., Andersen, C. L., Dyrskjot, L., Ørntoft, T., Lukas, J., Kittas, C., Helleday, T., Halazonetis, T. D., Bartek, J., & Gorgoulis, V. G.
- Affiliations
- The Wistar Institute (US)
- National and Kapodistrian University of Athens (GR)
- National Centre of Scientific Research "Demokritos" (GR)
- Stockholm University (SE)
- University of Ioannina (GR)
- National Hellenic Research Foundation (GR)
- University of Pennsylvania (US)
- Danish Cancer Society (DK)
- Copenhagen University Hospital (DK)
- Aarhus University Hospital (DK)
- Corresponding author
- Halazonetis, Thanos D.
- ORCID
- Venue
- Nature
- Published
- 2006-11
- Volume
- 444
- Issue
- 7119
- Pages
- 633-637
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2041156660
- Cited by
- 1,986
- References
- 30
- Citations by year
- 2026: 35 · 2025: 74 · 2024: 65 · 2023: 92 · 2022: 74 · 2021: 96 · 2020: 88 · 2019: 83 · 2018: 108 · 2017: 100 · 2016: 122 · 2015: 88 · 2014: 134 · 2013: 129 · 2012: 132
- FWCI
- 65.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- National Hellenic Research Foundation Helios Repository (National Hellenic Research Foundation) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- oncogene-induced senescence, DNA damage response, replication stress, DNA double-strand breaks, ATM kinase, precancerous lesions, senescence markers, tumor progression, apoptosis
- MeSH terms
- Animals, Cell Line, Cell Transformation, Neoplastic, DNA, DNA Damage, DNA Replication, Humans, Neoplasm Invasiveness, Nuclear Proteins, Oncogenes, Precancerous Conditions, Genes, mos, Cellular Senescence, Cell Cycle Proteins, Cyclin E, Cyclin-Dependent Kinase Inhibitor p16, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.